Publications

Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis  (2025)

Authors:
Lunghi, Barbara; Castagna, Annalisa; Branchini, Alessio; Baroni, Marcello; Marchetti, Giovanna; Mazzoni, Gianni; Legnani, Cristina; Spizzo, Marianna; Mango, Gabriele; Friso, Simonetta; Martinelli, Nicola; Bernardi, Francesco
Title:
Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis
Year:
2025
Type of item:
Articolo in Rivista
Tipologia ANVUR:
Articolo su rivista
Language:
Inglese
Format:
Elettronico
Referee:
Name of journal:
Thrombosis Research
ISSN of journal:
0049-3848
N° Volume:
251
Page numbers:
1-9
Keyword:
ABO blood-group; ASGR2; Aortic valve stenosis; CLEC4M; Factor VIII; LDLR; STAB2
Short description of contents:
Background: Altered blood flow, which characterizes aortic stenosis (AS), influences von Willebrand factor (VWF) conformation and enhances ADAMTS13 cleavage, potentially influencing factor VIII (FVIII) clearance and plasma levels. Aim: To investigate whether ABO blood group and genetic variants of cellular receptors involved in VWF/FVIII clearance may interact with AS in determining genotype-driven FVIII levels. Patients/methods: FVIII:c levels were analyzed in patients with severe AS (SAS, n = 115), with coronary artery disease and without valvular heart disease (CAD, n = 300), and healthy subjects (HS, n = 172), clustered according to ABO and receptor genotypes. Variants with functional association with receptor mRNA and/or FVIII levels, localized in 5 receptors (LDLR, STAB2, SCARA5, ASGR2, CLEC4M) with different VWF/FVIII binding properties, were selected. Results: In SAS group, a significant interaction between ABO and receptor genotypes in modulating FVIII:c levels was observed with positive B values for lectins (ASGR2 and CLEC4M) and negative for LDLR and STAB2. The lectin variants, as well as their combinations, showed significantly lower FVIII levels in the non-O group with high glycan expression and potentially improved FVIII binding and increased clearance. Differently, the non-lectin LDLR and STAB2 variants, and their combinations, were associated with genotype-driven high FVIII levels, particularly in the O group. All these patterns were not observed in CAD or HS groups. Conclusion: These observations suggest that differential interaction between genotypes of specific cellular receptors and ABO blood group may contribute to high/low FVIII:c levels in O/non-O blood group subjects, respectively, and to the large inter-individual variability of FVIII levels in SAS.
Web page:
https://doi.org/10.1016/j.thromres.2025.109356
Product ID:
146248
Handle IRIS:
11562/1164809
Last Modified:
June 14, 2025
Bibliographic citation:
Lunghi, Barbara; Castagna, Annalisa; Branchini, Alessio; Baroni, Marcello; Marchetti, Giovanna; Mazzoni, Gianni; Legnani, Cristina; Spizzo, Marianna; Mango, Gabriele; Friso, Simonetta; Martinelli, Nicola; Bernardi, Francesco, Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis «Thrombosis Research» , vol. 2512025pp. 1-9

Consulta la scheda completa presente nel repository istituzionale della Ricerca di Ateneo IRIS

<<back

Activities

Research facilities

Share